Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) Shares Outstanding (Weighted Average) (2016 - 2025)

Option Care Health (OPCH) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $162.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) fell 5.52% year-over-year to $162.1 million, compared with a TTM value of $162.1 million through Dec 2025, down 5.52%, and an annual FY2025 reading of $162.1 million, down 5.52% over the prior year.
  • Shares Outstanding (Weighted Average) was $162.1 million for Q4 2025 at Option Care Health, down from $163.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $181.9 million in Q3 2022 and bottomed at $162.1 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $175.4 million, with a median of $179.8 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 1.78% in 2021, then dropped 6.05% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $179.9 million in 2021, then rose by 0.7% to $181.1 million in 2022, then decreased by 1.18% to $179.0 million in 2023, then fell by 4.14% to $171.6 million in 2024, then decreased by 5.52% to $162.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for OPCH at $162.1 million in Q4 2025, $163.4 million in Q3 2025, and $162.9 million in Q2 2025.